LIXT Lixte Biotechnology
- 2.1500
- -0.0800-3.59%
Lixte Biotechnology News
8-K: Current report
10-Q: Q3 2024 Earnings Report
DEFA14A: Others
DEF 14A: Definitive information statements
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
4: Statement of changes in beneficial ownership of securities-Director Bernards Rene
4: Statement of changes in beneficial ownership of securities-Director Forman Stephen J.
4: Statement of changes in beneficial ownership of securities-Director Brown Regina
4: Statement of changes in beneficial ownership of securities-Director Yen Yun
PRE 14A: Preliminary proxy statements relating to merger or acquisition
8-K: Current report
S-1: General form for registration of securities under the Securities Act of 1933
8-K: Current report
8-K: Current report
8-K: Current report
8-K: Current report
10-Q: Q2 2024 Earnings Report
3: Initial statement of beneficial ownership of securities-Officer Schellens Johannes Henricus Matthias
8-K: Current report
Analysis
Price Target
No Data
No Data